Novel chemotherapy-free combination regimen for ibrutinib-resistant mantle cell lymphoma

Br J Haematol. 2018 May;181(4):561-564. doi: 10.1111/bjh.14669. Epub 2017 Apr 2.
No abstract available

Keywords: ibrutinib-resistant; mantle cell lymphoma; relapsed.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / analogs & derivatives
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Bortezomib / administration & dosage
  • Dexamethasone / administration & dosage
  • Drug Resistance, Neoplasm / drug effects*
  • Female
  • Humans
  • Lenalidomide / administration & dosage
  • Lymphoma, Mantle-Cell / drug therapy*
  • Male
  • Middle Aged
  • Piperidines
  • Pyrazoles / administration & dosage*
  • Pyrimidines / administration & dosage*
  • Rituximab / administration & dosage

Substances

  • Piperidines
  • Pyrazoles
  • Pyrimidines
  • ibrutinib
  • Rituximab
  • Bortezomib
  • Dexamethasone
  • Lenalidomide
  • Adenine